BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 11522091)

  • 1. Usefulness of long axis M-mode echocardiographic measurements for optimum dialysis in patients on maintenance hemodialysis: comparison with changes in plasma levels of atrial natriuretic peptide and brain natriuretic peptide.
    Sugihara K; Fujimoto S; Motomiya Y; Hashimoto T; Nakamura S; Dohi K
    Clin Nephrol; 2001 Aug; 56(2):140-9. PubMed ID: 11522091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma brain natriuretic peptide levels in chronic hemodialysis patients: influence of coronary artery disease.
    Nishikimi T; Futoo Y; Tamano K; Takahashi M; Suzuki T; Minami J; Honda T; Uetake S; Asakawa H; Kobayashi N; Horinaka S; Ishimitsu T; Matsuoka H
    Am J Kidney Dis; 2001 Jun; 37(6):1201-8. PubMed ID: 11382689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial and brain natriuretic peptide and endothelin-1 concentration in patients with idiopathic arterial hypertension: the dependence on the selected morphological parameters.
    Irzmański R; Banach M; Piechota M; Kowalski J; Barylski M; Cierniewski C; Pawlicki L
    Clin Exp Hypertens; 2007 Apr; 29(3):149-64. PubMed ID: 17497342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical significance of plasma atrial and brain natriuretic peptide levels during hemodialysis in hemodialysis patients with old myocardial infarction].
    Uetake S; Takahashi M; Tamano K; Honda T; Kobayashi T; Horinaka S
    J Cardiol; 2001 Aug; 38(2):61-71. PubMed ID: 11525111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between Doppler transmitral flow velocity pattern and plasma atrial and brain natriuretic peptide concentrations in anuric patients on maintenance hemodialysis.
    Ito S; Murai S; Takada N; Ozasa A; Hanada M; Sugiyama M; Suzuki K; Nagae Y; Inagaki T; Takeda Y; Fukutomi T; Joh T
    Int Heart J; 2006 May; 47(3):401-8. PubMed ID: 16823246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of lowered dialysate sodium on left ventricle function and brain natriuretic peptide in maintenance of hemodialysis patients.
    Akyol A; Akdag S; Asker M; Gumrukcuoglu HA; Duz R; Demirel KC; Ozturk F; Yaman M; Sahin M; Simsek H; Tuncer M; Begenik H
    Hum Exp Toxicol; 2017 Feb; 36(2):128-134. PubMed ID: 27009112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of natriuretic peptides and cyclic GMP in hemodialysis patients with coronary artery disease.
    Osajima A; Okazaki M; Kato H; Anai H; Tsuda Y; Segawa K; Tanaka H; Tamura M; Takasugi M; Nakashima Y
    Am J Nephrol; 2001; 21(2):112-9. PubMed ID: 11359018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of left ventricular diastolic function on natriuretic peptide levels after cardioversion of atrial fibrillation.
    Bakowski D; Wozakowska-Kapłon B; Opolski G
    Kardiol Pol; 2009 Apr; 67(4):361-7. PubMed ID: 19492248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natriuretic peptides during the development of doxorubicin-induced left ventricular diastolic dysfunction.
    Nousiainen T; Vanninen E; Jantunen E; Puustinen J; Remes J; Rantala A; Vuolteenaho O; Hartikainen J
    J Intern Med; 2002 Mar; 251(3):228-34. PubMed ID: 11886482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natriuretic peptides as markers of preclinical cardiac disease in obesity.
    Grandi AM; Laurita E; Selva E; Piantanida E; Imperiale D; Giovanella L; Guasti L; Venco A
    Eur J Clin Invest; 2004 May; 34(5):342-8. PubMed ID: 15147331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natriuretic peptides in patients with diastolic dysfunction due to idiopathic dilated cardiomyopathy.
    Fruhwald FM; Fahrleitner A; Watzinger N; Fruhwald S; Dobnig H; Schumacher M; Maier R; Zweiker R; Klein WW
    Eur Heart J; 1999 Oct; 20(19):1415-23. PubMed ID: 10487802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in brain natriuretic peptide and atrial natriuretic peptide plasma concentrations during hemodialysis in patients with chronic renal failure.
    Haug C; Metzele A; Steffgen J; Grünert A
    Horm Metab Res; 1994 May; 26(5):246-9. PubMed ID: 8076909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left atrial size by planimetry is superior to M-mode diameter: biochemical calibration by atrial and brain natriuretic peptide.
    Buchner S; Muscholl M; Debl K; Hense HW; Döring A; Stritzke J; Schunkert H; Jougasaki M; Burnett JC; Riegger GA; Luchner A
    J Am Soc Echocardiogr; 2008 Apr; 21(4):380-5. PubMed ID: 17681726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic potential of cardiac natriuretic peptides in dialysis patients.
    Mallamaci F; Zoccali C; Tripepi G; Benedetto FA; Parlongo S; Cataliotti A; Cutrupi S; Giacone G; Bellanuova I; Stancanelli B; Malatino LS;
    Kidney Int; 2001 Apr; 59(4):1559-66. PubMed ID: 11260421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of atrial and brain natriuretic polypeptides in association with angiotensin-converting enzyme gene polymorphism in Japanese non-diabetic hemodialysis patients.
    Nakao K; Kuze K; Abe H; Takahashi T; Doi T
    Scand J Urol Nephrol; 2007; 41(2):149-54. PubMed ID: 17454955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of left atrial global peak systolic strain with left ventricular diastolic dysfunction and brain natriuretic peptide level in end-stage renal disease patients with preserved left ventricular ejection fraction.
    Abid L; Charfeddine S; Kammoun S
    J Echocardiogr; 2016 Jun; 14(2):71-8. PubMed ID: 26861540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased brain natriuretic peptide and atrial natriuretic peptide plasma concentrations in dialysis-dependent chronic renal failure and in patients with elevated left ventricular filling pressure.
    Haug C; Metzele A; Steffgen J; Kochs M; Hombach V; Grünert A
    Clin Investig; 1994 Jun; 72(6):430-4. PubMed ID: 7950153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma concentration of brain natriuretic peptide as an indicator of cardiac ventricular function in patients on hemodialysis.
    Nitta K; Kawashima A; Yumura W; Naruse M; Oba T; Kabaya T; Nihei H
    Am J Nephrol; 1998; 18(5):411-5. PubMed ID: 9730565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of plasma levels of mature adrenomedullin and natriuretic peptide as markers of cardiac function in hemodialysis patients with coronary artery disease.
    Osajima A; Okazaki M; Tamura M; Anai H; Kabashima N; Suda T; Iwamoto M; Ota T; Watanabe Y; Kanegae K; Nakashima Y
    Nephron; 2002 Dec; 92(4):832-9. PubMed ID: 12399629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and echocardiographic correlates of improvement in left ventricular diastolic function after cardiac resynchronization therapy.
    Aksoy H; Okutucu S; Kaya EB; Deveci OS; Evranos B; Aytemir K; Kabakci G; Tokgozoglu L; Ozkutlu H; Oto A
    Europace; 2010 Sep; 12(9):1256-61. PubMed ID: 20478931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.